WHAT:

WHAT:            Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will outline new information from the Food and Drug Administration (FDA) on the new coronavirus (COVID-19) pandemic as it relates to ongoing and planned clinical research in an upcoming webinar, “Potential COVID-19 Products: Choosing the Right Path with FDA.” The webinar will take place on Thursday, May 7, from 1-1:30 p.m. EST.

Rho’s Vice President of Regulatory Strategy and Submissions Kevin Barber and Research Scientist Theresa Scocca will present the webinar, which will provide insights on FDA pathways sponsors should consider in development of a product for treatment of COVID-19 or COVID-19-related indications. This webinar will explain which pathways might be considered based on the development phase and overall goals for a product, as well as discuss the information and data necessary to help FDA expeditiously review and move proposals forward.

WHO:              Kevin Barber, Ph.D., vice president of regulatory strategy and submissions at Rho

Theresa Scocca, Ph.D., research scientist at Rho 

WHEN:            May 7, 2020
                       1-1:30 p.m. EST

WHERE:          Register to attend this free webinar at this link.

DETAILS:        For media inquiries, please contact Melody Goforth at Largemouth Communications, 919-459-  6482, melody@largemouthpr.com.   

ABOUT:           Rho, a privately-held contract research organization (CRO) located in NC’s Research Triangle Park, provides a full range of drug development services from program strategy through clinical trials and marketing applications. For more than 35 years, Rho has been a trusted partner to some of the industry’s most innovative pharmaceutical, biotechnology and medical device companies, as well as academic and government organizations. Rho’s cross-functional collaborative approach, therapeutic expertise, and commitment to strong site relationships changes what it means to work with a CRO – ultimately accelerating time to market, maximizing returns on investment, and ensuring a consistent program that runs smarter and more efficiently. Experience Rho by following us on Facebook, LinkedIn and Twitter.

###